{"transactions":[{"id":978737,"issuer":{"id":928,"kind":"organization","name":"Qnity Electronics, Inc.","symbol":"Q"},"owners":[{"id":72137,"kind":"person","name":"Harbaugh Matthew K","position":1,"cik":"0001578368","reported_name":"Harbaugh Matthew K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options (Right to Buy) NQOs","published_at":"2025-12-05T21:13:41.000Z","date":"2025-12-03","kind":"grant","planned":false,"acquired":true,"shares":49807,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":49807,"derivative":{"exercise_price":80.28,"exercise_date":"2028-12-03","expiration_date":"2035-12-02","underlying":"Common Stock","underlying_shares":49807},"source":{"system":"sec-edgar","filing":"0001628280-25-055669","document":"wk-form4_1764987218.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1578368/000162828025055669/wk-form4_1764987218.xml","form_type":"4"}},{"id":1007842,"issuer":{"id":928,"kind":"organization","name":"Qnity Electronics, Inc.","symbol":"Q"},"owners":[{"id":72137,"kind":"person","name":"Harbaugh Matthew K","position":1,"cik":"0001578368","reported_name":"Harbaugh Matthew K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-11-04T19:26:02.000Z","date":"2025-11-01","kind":"other","planned":false,"acquired":true,"shares":9291.5511,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On November 1, 2025, the Reporting Person received a dividend of one (1) share of Qnity Electronics, Inc. (\"Qnity\") common stock for every two (2) shares of DuPont de Nemours, Inc. (\"DuPont\") held by the Reporting Person, and the Reporting Person's equity awards denominated in DuPont common stock were adjusted, in part, into equity awards denominated in Qnity common stock, all as described in Qnity's information statement filed as Exhibit 99.1 to the Current Report on Form 8-K that was filed by Qnity with the Securities and Exchange Commission on October 15, 2025, in connection with the spin-off of Qnity from DuPont. This amount includes restricted stock units and dividend equivalent units."}],"balance_after":9291.5511,"source":{"system":"sec-edgar","filing":"0001628280-25-049142","document":"wk-form4_1762302359.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1578368/000162828025049142/wk-form4_1762302359.xml","form_type":"4"}},{"id":1789581,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":72137,"kind":"person","name":"Harbaugh Matthew K","position":1,"cik":"0001578368","reported_name":"Harbaugh Matthew K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Performance Restricted Stock Unit","published_at":"2023-09-05T16:34:03.000Z","date":"2023-09-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":14677,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Represented a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each performance restricted stock unit award was converted into a Globus restricted stock unit award, with the number of shares of Globus Class A Common Stock subject to such assumed award determined based on the Exchange Ratio and with applicable performance conditions deemed to be achieved at 100% of the target performance level.  Each converted Globus restricted stock unit award is subject to the same terms and conditions (including service-based vesting conditions but excluding performance-based vesting conditions) as applied to the corresponding Issuer performance restricted stock unit award subject to such award as of immediately prior to the Effective Time"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each performance restricted stock unit award was converted into a Globus restricted stock unit award, with the number of shares of Globus Class A Common Stock subject to such assumed award determined based on the Exchange Ratio and with applicable performance conditions deemed to be achieved at 100% of the target performance level.  Each converted Globus restricted stock unit award is subject to the same terms and conditions (including service-based vesting conditions but excluding performance-based vesting conditions) as applied to the corresponding Issuer performance restricted stock unit award subject to such award as of immediately prior to the Effective Time"}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":14677},"source":{"system":"sec-edgar","filing":"0001209191-23-048171","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919123048171/doc4.xml","form_type":"4"}},{"id":1789580,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":72137,"kind":"person","name":"Harbaugh Matthew K","position":1,"cik":"0001578368","reported_name":"Harbaugh Matthew K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Performance Restricted Stock Unit","published_at":"2023-09-05T16:34:03.000Z","date":"2023-09-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":13411,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Represented a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each performance restricted stock unit award was converted into a Globus restricted stock unit award, with the number of shares of Globus Class A Common Stock subject to such assumed award determined based on the Exchange Ratio and with applicable performance conditions deemed to be achieved at 100% of the target performance level.  Each converted Globus restricted stock unit award is subject to the same terms and conditions (including service-based vesting conditions but excluding performance-based vesting conditions) as applied to the corresponding Issuer performance restricted stock unit award subject to such award as of immediately prior to the Effective Time"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each performance restricted stock unit award was converted into a Globus restricted stock unit award, with the number of shares of Globus Class A Common Stock subject to such assumed award determined based on the Exchange Ratio and with applicable performance conditions deemed to be achieved at 100% of the target performance level.  Each converted Globus restricted stock unit award is subject to the same terms and conditions (including service-based vesting conditions but excluding performance-based vesting conditions) as applied to the corresponding Issuer performance restricted stock unit award subject to such award as of immediately prior to the Effective Time"}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":13411},"source":{"system":"sec-edgar","filing":"0001209191-23-048171","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919123048171/doc4.xml","form_type":"4"}},{"id":1789579,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":72137,"kind":"person","name":"Harbaugh Matthew K","position":1,"cik":"0001578368","reported_name":"Harbaugh Matthew K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Restricted Stock Unit","published_at":"2023-09-05T16:34:03.000Z","date":"2023-09-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":37498,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Represented a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit award was converted into a Globus restricted stock unit award, with the number of shares of Globus Class A Common Stock subject to such assumed award determined based on the Exchange Ratio.  Each converted Globus restricted stock unit award is subject to the same terms and conditions (including service-based vesting conditions) as applied to the corresponding Issuer restricted stock unit award as of immediately prior to the Effective Time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit award was converted into a Globus restricted stock unit award, with the number of shares of Globus Class A Common Stock subject to such assumed award determined based on the Exchange Ratio.  Each converted Globus restricted stock unit award is subject to the same terms and conditions (including service-based vesting conditions) as applied to the corresponding Issuer restricted stock unit award as of immediately prior to the Effective Time."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":37498},"source":{"system":"sec-edgar","filing":"0001209191-23-048171","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919123048171/doc4.xml","form_type":"4"}},{"id":1789578,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":72137,"kind":"person","name":"Harbaugh Matthew K","position":1,"cik":"0001578368","reported_name":"Harbaugh Matthew K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Restricted Stock Unit","published_at":"2023-09-05T16:34:03.000Z","date":"2023-09-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":14677,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Represented a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit award was converted into a Globus restricted stock unit award, with the number of shares of Globus Class A Common Stock subject to such assumed award determined based on the Exchange Ratio.  Each converted Globus restricted stock unit award is subject to the same terms and conditions (including service-based vesting conditions) as applied to the corresponding Issuer restricted stock unit award as of immediately prior to the Effective Time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit award was converted into a Globus restricted stock unit award, with the number of shares of Globus Class A Common Stock subject to such assumed award determined based on the Exchange Ratio.  Each converted Globus restricted stock unit award is subject to the same terms and conditions (including service-based vesting conditions) as applied to the corresponding Issuer restricted stock unit award as of immediately prior to the Effective Time."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":14677},"source":{"system":"sec-edgar","filing":"0001209191-23-048171","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919123048171/doc4.xml","form_type":"4"}},{"id":1789577,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":72137,"kind":"person","name":"Harbaugh Matthew K","position":1,"cik":"0001578368","reported_name":"Harbaugh Matthew K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Restricted Stock Unit","published_at":"2023-09-05T16:34:03.000Z","date":"2023-09-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":13411,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Represented a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit award was converted into a Globus restricted stock unit award, with the number of shares of Globus Class A Common Stock subject to such assumed award determined based on the Exchange Ratio.  Each converted Globus restricted stock unit award is subject to the same terms and conditions (including service-based vesting conditions) as applied to the corresponding Issuer restricted stock unit award as of immediately prior to the Effective Time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit award was converted into a Globus restricted stock unit award, with the number of shares of Globus Class A Common Stock subject to such assumed award determined based on the Exchange Ratio.  Each converted Globus restricted stock unit award is subject to the same terms and conditions (including service-based vesting conditions) as applied to the corresponding Issuer restricted stock unit award as of immediately prior to the Effective Time."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":13411},"source":{"system":"sec-edgar","filing":"0001209191-23-048171","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919123048171/doc4.xml","form_type":"4"}},{"id":1789576,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":72137,"kind":"person","name":"Harbaugh Matthew K","position":1,"cik":"0001578368","reported_name":"Harbaugh Matthew K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common Stock, par value $0.001 per share","published_at":"2023-09-05T16:34:03.000Z","date":"2023-09-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":11081,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of February 8, 2023 (the \"Merger Agreement\"), by and among the Issuer, Globus Medical, Inc. (\"Globus\") and Zebra Merger Sub, Inc. (\"Merger Sub\"), Merger Sub merged with and into the Issuer, with the Issuer continuing as a wholly owned subsidiary of Globus. At the effective time of the merger (the \"Effective Time\"), each share of the Issuer's common stock issued and outstanding immediately prior to the Effective Time (other than certain excluded shares) was cancelled and converted into the right to receive 0.75 shares of Class A common stock of Globus  (\"Globus Class A Common Stock\"), par value $0.001 per share (the \"Exchange Ratio\" and such shares, the \"Merger Consideration\"), and cash in lieu of fractional shares."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-048171","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919123048171/doc4.xml","form_type":"4"}},{"id":1975059,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":72137,"kind":"person","name":"Harbaugh Matthew K","position":1,"cik":"0001578368","reported_name":"Harbaugh Matthew K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"RSUs","published_at":"2023-03-03T17:47:26.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":37498,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This RSU award was granted to the Reporting Person on March 1, 2023. In accordance with the terms of the RSU award, the award will vest in full on March 1, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"This RSU award was granted to the Reporting Person on March 1, 2023. In accordance with the terms of the RSU award, the award will vest in full on March 1, 2026."}],"balance_after":37498,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":37498},"source":{"system":"sec-edgar","filing":"0001209191-23-015847","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919123015847/doc4.xml","form_type":"4"}},{"id":1975058,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":72137,"kind":"person","name":"Harbaugh Matthew K","position":1,"cik":"0001578368","reported_name":"Harbaugh Matthew K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"RSUs","published_at":"2023-03-03T17:47:26.000Z","date":"2023-03-01","kind":"exercise","acquired":false,"shares":12190,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This RSU award was granted to the Reporting Person on March 2, 2020. In accordance with the terms of the RSU award, the award vested as to 12,190 shares on March 1, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"This RSU award was granted to the Reporting Person on March 2, 2020. In accordance with the terms of the RSU award, the award vested as to 12,190 shares on March 1, 2023."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":12190},"source":{"system":"sec-edgar","filing":"0001209191-23-015847","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919123015847/doc4.xml","form_type":"4"}},{"id":1975057,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":72137,"kind":"person","name":"Harbaugh Matthew K","position":1,"cik":"0001578368","reported_name":"Harbaugh Matthew K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2023-03-03T17:47:26.000Z","date":"2023-03-01","kind":"tax_withholding","acquired":false,"shares":3526,"price":42.67,"value":150454.42,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld by the Issuer to satisfy tax withholding obligations."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Issuer equity awards."}],"balance_after":10522,"source":{"system":"sec-edgar","filing":"0001209191-23-015847","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919123015847/doc4.xml","form_type":"4"}},{"id":1975056,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":72137,"kind":"person","name":"Harbaugh Matthew K","position":1,"cik":"0001578368","reported_name":"Harbaugh Matthew K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2023-03-03T17:47:26.000Z","date":"2023-03-01","kind":"exercise","acquired":true,"shares":12190,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Issuer equity awards."}],"balance_after":14048,"source":{"system":"sec-edgar","filing":"0001209191-23-015847","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919123015847/doc4.xml","form_type":"4"}},{"id":2072977,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":72137,"kind":"person","name":"Harbaugh Matthew K","position":1,"cik":"0001578368","reported_name":"Harbaugh Matthew K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"RSUs","published_at":"2023-01-03T17:54:38.000Z","date":"2023-01-01","kind":"exercise","acquired":false,"shares":1286,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This RSU award was granted to the Reporting Person on January 2, 2020. In accordance with the terms of the RSU award, the award vested as to 1,286 shares on January 1, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"This RSU award was granted to the Reporting Person on January 2, 2020. In accordance with the terms of the RSU award, the award vested as to 1,286 shares on January 1, 2023."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":1286},"source":{"system":"sec-edgar","filing":"0001209191-23-000364","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919123000364/doc4.xml","form_type":"4"}},{"id":2072976,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":72137,"kind":"person","name":"Harbaugh Matthew K","position":1,"cik":"0001578368","reported_name":"Harbaugh Matthew K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2023-01-03T17:54:38.000Z","date":"2023-01-01","kind":"tax_withholding","acquired":false,"shares":440,"price":41.24,"value":18145.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld by the Issuer to satisfy tax withholding obligations."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Issuer equity awards. Amount includes 555 shares acquired under the Issuer's employee stock purchase plan in April 2021 and 457 shares acquired under the Issuer's employee stock purchase plan in April 2022."}],"balance_after":1858,"source":{"system":"sec-edgar","filing":"0001209191-23-000364","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919123000364/doc4.xml","form_type":"4"}},{"id":2072975,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":72137,"kind":"person","name":"Harbaugh Matthew K","position":1,"cik":"0001578368","reported_name":"Harbaugh Matthew K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2023-01-03T17:54:38.000Z","date":"2023-01-01","kind":"exercise","acquired":true,"shares":1286,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Issuer equity awards. Amount includes 555 shares acquired under the Issuer's employee stock purchase plan in April 2021 and 457 shares acquired under the Issuer's employee stock purchase plan in April 2022."}],"balance_after":2298,"source":{"system":"sec-edgar","filing":"0001209191-23-000364","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919123000364/doc4.xml","form_type":"4"}},{"id":2355670,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":72137,"kind":"person","name":"Harbaugh Matthew K","position":1,"cik":"0001578368","reported_name":"Harbaugh Matthew K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"RSUs","published_at":"2022-03-03T17:50:11.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":14677,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This RSU award was granted to the Reporting Person on March 1, 2022. In accordance with the terms of the RSU award, the award will vest in full on March 1, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This RSU award was granted to the Reporting Person on March 1, 2022. In accordance with the terms of the RSU award, the award will vest in full on March 1, 2025."}],"balance_after":14677,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":14677},"source":{"system":"sec-edgar","filing":"0001209191-22-015762","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919122015762/doc4.xml","form_type":"4"}},{"id":2814827,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":72137,"kind":"person","name":"Harbaugh Matthew K","position":1,"cik":"0001578368","reported_name":"Harbaugh Matthew K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"RSUs","published_at":"2021-03-03T17:49:42.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":13411,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This RSU award was granted to the Reporting Person on March 1, 2021. In accordance with the terms of the RSU award, the award will vest in full on March 1, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This RSU award was granted to the Reporting Person on March 1, 2021. In accordance with the terms of the RSU award, the award will vest in full on March 1, 2024."}],"balance_after":13411,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":13411},"source":{"system":"sec-edgar","filing":"0001209191-21-017144","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919121017144/doc4.xml","form_type":"4"}},{"id":3233421,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":72137,"kind":"person","name":"Harbaugh Matthew K","position":1,"cik":"0001578368","reported_name":"Harbaugh Matthew K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"RSUs","published_at":"2020-03-03T17:50:17.000Z","date":"2020-03-02","kind":"grant","acquired":true,"shares":12190,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This RSU award was granted to the Reporting Person on March 2, 2020. In accordance with the terms of the RSU award, the award will vest in full on March 1, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This RSU award was granted to the Reporting Person on March 2, 2020. In accordance with the terms of the RSU award, the award will vest in full on March 1, 2023."}],"balance_after":12190,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":12190},"source":{"system":"sec-edgar","filing":"0001209191-20-015520","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919120015520/doc4.xml","form_type":"4"}},{"id":3323738,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":72137,"kind":"person","name":"Harbaugh Matthew K","position":1,"cik":"0001578368","reported_name":"Harbaugh Matthew K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"RSUs","published_at":"2020-01-03T17:49:31.000Z","date":"2020-01-02","kind":"grant","acquired":true,"shares":1286,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This RSU award was granted to the Reporting Person on January 2, 2020. In accordance with the terms of the RSU award, the award will vest as to 1,286 shares on January 1, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This RSU award was granted to the Reporting Person on January 2, 2020. In accordance with the terms of the RSU award, the award will vest as to 1,286 shares on January 1, 2023."}],"balance_after":1286,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":1286},"source":{"system":"sec-edgar","filing":"0001209191-20-001324","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919120001324/doc4.xml","form_type":"4"}},{"id":3563744,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":72137,"kind":"person","name":"Harbaugh Matthew K","position":1,"cik":"0001578368","reported_name":"Harbaugh Matthew K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, Spec Gen"}}],"security":"Ordinary Shares","published_at":"2019-04-03T21:27:21.000Z","date":"2019-04-02","kind":"tax_withholding","acquired":false,"shares":2533,"price":22.8,"value":57752.4,"ownership":{"direct":true},"balance_after":104115,"source":{"system":"sec-edgar","filing":"0000950138-19-000215","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000095013819000215/edgar.xml","form_type":"4"}},{"id":3701602,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":72137,"kind":"person","name":"Harbaugh Matthew K","position":1,"cik":"0001578368","reported_name":"Harbaugh Matthew K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Spec Gen"}}],"security":"Ordinary Shares","published_at":"2019-01-07T22:47:19.000Z","date":"2019-01-04","kind":"tax_withholding","acquired":false,"shares":656,"price":17.21,"value":11289.76,"ownership":{"direct":true},"balance_after":106648,"source":{"system":"sec-edgar","filing":"0000950138-19-000017","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000095013819000017/edgar.xml","form_type":"4"}},{"id":3701601,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":72137,"kind":"person","name":"Harbaugh Matthew K","position":1,"cik":"0001578368","reported_name":"Harbaugh Matthew K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Spec Gen"}}],"security":"Ordinary Shares","published_at":"2019-01-07T22:47:19.000Z","date":"2019-01-03","kind":"tax_withholding","acquired":false,"shares":1180,"price":16.14,"value":19045.2,"ownership":{"direct":true},"balance_after":107304,"source":{"system":"sec-edgar","filing":"0000950138-19-000017","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000095013819000017/edgar.xml","form_type":"4"}},{"id":3703148,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":72137,"kind":"person","name":"Harbaugh Matthew K","position":1,"cik":"0001578368","reported_name":"Harbaugh Matthew K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Spec Gen"}}],"security":"Ordinary Shares","published_at":"2019-01-04T22:45:31.000Z","date":"2019-01-02","kind":"tax_withholding","acquired":false,"shares":341,"price":16.59,"value":5657.19,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 704 shares acquired between June 30, 2018 and December 31, 2018 under the Mallinckrodt employee stock purchase plan."}],"balance_after":108484,"source":{"system":"sec-edgar","filing":"0000950138-19-000003","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000095013819000003/edgar.xml","form_type":"4"}},{"id":3969070,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":72137,"kind":"person","name":"Harbaugh Matthew K","position":1,"cik":"0001578368","reported_name":"Harbaugh Matthew K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP & CFO"}}],"security":"Employee Share Options (Right to Buy)","published_at":"2018-04-04T22:05:43.000Z","date":"2018-04-02","kind":"grant","acquired":true,"shares":177849,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vest in four equal annual installments beginning April 2, 2019."}],"balance_after":177849,"derivative":{"exercise_price":13.8,"exercise_date":"2019-04-02","expiration_date":"2028-04-02","underlying":"Ordinary Shares","underlying_shares":177849},"source":{"system":"sec-edgar","filing":"0000950138-18-000309","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000095013818000309/edgar.xml","form_type":"4"}},{"id":3969069,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":72137,"kind":"person","name":"Harbaugh Matthew K","position":1,"cik":"0001578368","reported_name":"Harbaugh Matthew K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP & CFO"}}],"security":"Ordinary Shares","published_at":"2018-04-04T22:05:43.000Z","date":"2018-04-02","kind":"grant","acquired":true,"shares":34058,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest in four equal annual installments beginning April 2, 2019."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 623 shares acquired on March 31, 2018 under the Mallinckrodt employee stock purchase plan."}],"balance_after":108121,"source":{"system":"sec-edgar","filing":"0000950138-18-000309","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000095013818000309/edgar.xml","form_type":"4"}},{"id":4105034,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":72137,"kind":"person","name":"Harbaugh Matthew K","position":1,"cik":"0001578368","reported_name":"Harbaugh Matthew K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP & CFO"}}],"security":"Ordinary Shares","published_at":"2018-01-06T00:16:08.000Z","date":"2018-01-04","kind":"tax_withholding","acquired":false,"shares":838,"price":23.4,"value":19609.2,"ownership":{"direct":true},"balance_after":73440,"source":{"system":"sec-edgar","filing":"0000950138-18-000035","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000095013818000035/edgar.xml","form_type":"4"}},{"id":4105033,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":72137,"kind":"person","name":"Harbaugh Matthew K","position":1,"cik":"0001578368","reported_name":"Harbaugh Matthew K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP & CFO"}}],"security":"Ordinary Shares","published_at":"2018-01-06T00:16:08.000Z","date":"2018-01-03","kind":"tax_withholding","acquired":false,"shares":1508,"price":23.51,"value":35453.08,"ownership":{"direct":true},"balance_after":74278,"source":{"system":"sec-edgar","filing":"0000950138-18-000035","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000095013818000035/edgar.xml","form_type":"4"}},{"id":4106653,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":72137,"kind":"person","name":"Harbaugh Matthew K","position":1,"cik":"0001578368","reported_name":"Harbaugh Matthew K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP & CFO"}}],"security":"Ordinary Shares","published_at":"2018-01-05T00:21:23.000Z","date":"2018-01-02","kind":"tax_withholding","acquired":false,"shares":1610,"price":23.52,"value":37867.2,"ownership":{"direct":true},"balance_after":75786,"source":{"system":"sec-edgar","filing":"0000950138-18-000028","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000095013818000028/edgar.xml","form_type":"4"}},{"id":4106652,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":72137,"kind":"person","name":"Harbaugh Matthew K","position":1,"cik":"0001578368","reported_name":"Harbaugh Matthew K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP & CFO"}}],"security":"Ordinary Shares","published_at":"2018-01-05T00:21:23.000Z","date":"2018-01-02","kind":"grant","acquired":true,"shares":2404,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Vesting of performance share award granted on January 2, 2015."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 324 shares acquired between June 30, 2017 and September 30, 2017 under the Mallinckrodt employee stock purchase plan."}],"balance_after":77396,"source":{"system":"sec-edgar","filing":"0000950138-18-000028","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000095013818000028/edgar.xml","form_type":"4"}},{"id":4263296,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":72137,"kind":"person","name":"Harbaugh Matthew K","position":1,"cik":"0001578368","reported_name":"Harbaugh Matthew K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP & CFO"}}],"security":"Ordinary Shares","published_at":"2017-07-05T20:19:34.000Z","date":"2017-07-01","kind":"tax_withholding","acquired":false,"shares":1620,"price":44.81,"value":72592.2,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 203 shares acquired on March 31, 2017 under the Mallinckrodt employee stock purchase plan."}],"balance_after":74668,"source":{"system":"sec-edgar","filing":"0000950138-17-000518","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000095013817000518/edgar.xml","form_type":"4"}},{"id":4385824,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":72137,"kind":"person","name":"Harbaugh Matthew K","position":1,"cik":"0001578368","reported_name":"Harbaugh Matthew K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP & CFO"}}],"security":"Ordinary Shares","published_at":"2017-03-14T12:40:00.000Z","date":"2017-03-10","kind":"purchase","acquired":true,"shares":600,"price":49.19,"value":29514.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price represents a weighted average. The shares were purchased in multiple transactions at prices ranging from $49.18 to $49.22, inclusive. Mr. Harbaugh will provide, upon request of the SEC staff, Mallinckrodt plc or a shareholder of Mallinckrodt plc complete information regarding the number of shares sold at each price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 156 shares acquired on December 31, 2016, under the Mallinckrodt employee stock purchase plan."}],"balance_after":76085,"source":{"system":"sec-edgar","filing":"0000950138-17-000319","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000095013817000319/edgar.xml","form_type":"4"}},{"id":4496032,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":72137,"kind":"person","name":"Harbaugh Matthew K","position":1,"cik":"0001578368","reported_name":"Harbaugh Matthew K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP & CFO"}}],"security":"Ordinary Shares","published_at":"2017-01-06T23:12:48.000Z","date":"2017-01-04","kind":"tax_withholding","acquired":false,"shares":724,"price":53.19,"value":38509.56,"ownership":{"direct":true},"balance_after":75329,"source":{"system":"sec-edgar","filing":"0000950138-17-000051","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000095013817000051/edgar.xml","form_type":"4"}},{"id":4501537,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":72137,"kind":"person","name":"Harbaugh Matthew K","position":1,"cik":"0001578368","reported_name":"Harbaugh Matthew K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP & CFO"}}],"security":"Employee Share Options (Right to Buy)","published_at":"2017-01-05T01:42:16.000Z","date":"2017-01-03","kind":"grant","acquired":true,"shares":63397,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The options vest in their entirety on January 3, 2021."}],"balance_after":63397,"derivative":{"exercise_price":51.73,"exercise_date":"2021-01-03","expiration_date":"2027-01-03","underlying":"Ordinary Shares","underlying_shares":63397},"source":{"system":"sec-edgar","filing":"0000950138-17-000014","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000095013817000014/edgar.xml","form_type":"4"}},{"id":4501536,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":72137,"kind":"person","name":"Harbaugh Matthew K","position":1,"cik":"0001578368","reported_name":"Harbaugh Matthew K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP & CFO"}}],"security":"Employee Share Options (Right to Buy)","published_at":"2017-01-05T01:42:16.000Z","date":"2017-01-03","kind":"grant","acquired":true,"shares":74675,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options vest in four equal annual installments beginning January 3, 2018."}],"balance_after":74675,"derivative":{"exercise_price":51.73,"exercise_date":"2018-01-03","expiration_date":"2027-01-03","underlying":"Ordinary Shares","underlying_shares":74675},"source":{"system":"sec-edgar","filing":"0000950138-17-000014","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000095013817000014/edgar.xml","form_type":"4"}},{"id":4501535,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":72137,"kind":"person","name":"Harbaugh Matthew K","position":1,"cik":"0001578368","reported_name":"Harbaugh Matthew K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP & CFO"}}],"security":"Ordinary Shares","published_at":"2017-01-05T01:42:16.000Z","date":"2017-01-03","kind":"grant","acquired":true,"shares":1718,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents restricted stock units that vest in three equal annual installments beginning January 3, 2018."}],"balance_after":76053,"source":{"system":"sec-edgar","filing":"0000950138-17-000014","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000095013817000014/edgar.xml","form_type":"4"}},{"id":4501534,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":72137,"kind":"person","name":"Harbaugh Matthew K","position":1,"cik":"0001578368","reported_name":"Harbaugh Matthew K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP & CFO"}}],"security":"Ordinary Shares","published_at":"2017-01-05T01:42:16.000Z","date":"2017-01-03","kind":"grant","acquired":true,"shares":13293,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted stock units that vest in four equal annual installments beginning January 3, 2018."}],"balance_after":74335,"source":{"system":"sec-edgar","filing":"0000950138-17-000014","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000095013817000014/edgar.xml","form_type":"4"}},{"id":4501533,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":72137,"kind":"person","name":"Harbaugh Matthew K","position":1,"cik":"0001578368","reported_name":"Harbaugh Matthew K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP & CFO"}}],"security":"Ordinary Shares","published_at":"2017-01-05T01:42:16.000Z","date":"2017-01-02","kind":"tax_withholding","acquired":false,"shares":4334,"price":49.82,"value":215919.88,"ownership":{"direct":true},"balance_after":61042,"source":{"system":"sec-edgar","filing":"0000950138-17-000014","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000095013817000014/edgar.xml","form_type":"4"}},{"id":4501532,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":72137,"kind":"person","name":"Harbaugh Matthew K","position":1,"cik":"0001578368","reported_name":"Harbaugh Matthew K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP & CFO"}}],"security":"Ordinary Shares","published_at":"2017-01-05T01:42:16.000Z","date":"2017-01-02","kind":"grant","acquired":true,"shares":10864,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Vesting of performance share award granted on January 2, 2014."}],"balance_after":65376,"source":{"system":"sec-edgar","filing":"0000950138-17-000014","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000095013817000014/edgar.xml","form_type":"4"}},{"id":4530930,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":72137,"kind":"person","name":"Harbaugh Matthew K","position":1,"cik":"0001578368","reported_name":"Harbaugh Matthew K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP & CFO"}}],"security":"Ordinary Shares","published_at":"2016-12-06T13:22:18.000Z","date":"2016-12-03","kind":"tax_withholding","acquired":false,"shares":297,"price":53.61,"value":15922.17,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 191 shares acquired between July 5, 2016 and September 30, 2016, under the Mallinckrodt employee stock purchase plan."}],"balance_after":54512,"source":{"system":"sec-edgar","filing":"0000950138-16-001491","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000095013816001491/edgar.xml","form_type":"4"}}]}